Genzyme
-
Sanofi appoints David Meeker Chief Executive Officer of Genzyme
Christopher A Viehbacher will retain the position of Chairman, Genzyme.
Genzyme | 24 October 2011
-
Genzyme announces winners of Patient Advocacy Leadership awards
Genzyme, a Sanofi company, announced the first recipients of the Genzyme Patient Advocacy Leadership (PAL) Awards. This global grant program supports non-profit organizations that work on behalf of patients living with lysosomal storage disorders (LS…
Genzyme | 17 August 2011
-
Sanofi provides updates on Genzyme product supply
Since the beginning of the year, Genzyme has been able to supply Cerezyme(imiglucerase for injection) to patients globally at normal dosing levels and has maintained consistent supply of Fabrazyme (algalsidase beta) to current patients at a reduced d…
Genzyme | 28 July 2011
-
Genzyme celebrates 20th anniversary of Gaucher disease registry
Genzyme, a Sanofi company, announced the launch of a new web-based platform, RegistryNXT!SM, to support the International Collaborative Gaucher Group (ICGG) Gaucher Registry. Said to be the first and largest database of its kind in the world, the glo…
Genzyme | 16 June 2011
-
Sanofi-Aventis acquires Genzyme
Sanofi-aventis announced that it has completed its acquisition of Genzyme Corporation, which is now a wholly-owned subsidiary of Sanofi-aventis. According to the company, Genzyme will become an important new platform in its sustainable growth st…
Genzyme | 01 May 2011
-
Sanofi-Aventis completes acquisition of Genzyme Corporation
Sanofi-aventis announced that it has completed its acquisition of Genzyme Corporation, which is now a wholly-owned subsidiary of Sanofi-aventis. According to the company, Genzyme will become an important new platform in its sustainable growth strateg…
Genzyme | 09 April 2011
-
Genzyme presents new data from alemtuzumab phase 2 MS trial
Genzyme announcedthat it will present new data from its completed phase 2 trial of the investigational drug alemtuzumab for multiple sclerosis (MS) at the American Academy of Neurology's (AAN) 63rd Annual Meeting in Hawaii, April 9 - 16, 2011. Includ…
Genzyme | 07 April 2011
-
Genzyme Opens New Science Center for Early Stage Research
Genzyme Corp has marked the opening of its new science center in Framingham, Massachusetts. The facility will serve as a central site for early stage research, where scientists can utilize the technologies available to discover new treatments for …
Genzyme | 01 November 2008
-
Study Results between alemtuzumab and Rebif
Genzyme Corp and Bayer HealthCare Pharmaceuticals have announced study results showing that patients with early relapsing-remitting multiple sclerosis (RRMS) taking once-yearly cycles of alemtuzumab reduced their risk of relapse by 74% and the risk o…
Genzyme | 31 October 2008
-
Genzyme and Isis complete licensing of mipomersen
Genzyme Corp. and Isis Pharmaceuticals, Inc. has announced the finalization of the license and collaboration agreement for mipomersen. The collaboration provides Genzyme with exclusive worldwide rights to mipomersen, a novel lipid-lowering drug d…
Genzyme | 01 July 2008
